Kymera Therapeutics
About:
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Website: http://www.kymeratx.com/
Twitter/X: kymeratx
Top Investors: BlackRock, Wellington Management, Bessemer Venture Partners, MRL Ventures Fund, Vertex Pharmaceuticals
Description:
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. It features a proprietary predictive modeling degradation platform with a novel small molecule modality to accelerate the drug discovery designed for disease-causing proteins.
$1.1B
$50M to $100M
Cambridge, Massachusetts, United States
2017-01-01
inquiries(AT)kymeratx.com
Nello Mainolfi
101-250
2024-08-19
Public
© 2025 bioDAO.ai